Thermal stabilization and self-administered delivery of heat-sensitive medical countermeasures using room temperature dehydration technology resulting in a phase II small business innovation…
Active Definitive Contract Awarded Last action
- Contract number
- W911SR26CA013
- Awardee
-
Inaedis, Inc. UEI ZN3PYM5VY1W9
- Awarding agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Obligated
- $1,396,936
Award facts
- Opportunity
-
- W911SR25SDTRA Solicitation number
- Contract value 100% obligated
- $1,396,936.32 Current and potential, with all options
- Completion date 29% complete
- Current and potential, with all options
- Funding agency
- Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 13 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Princeton, NJ, USA
- Research
- SBIR Program Phase I Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $1,396,936 |
About this award
The Joint PEO Chemical and Biological Defense awarded a $1.396 million definitive contract to Inaedis, Inc. on April 13, 2026, for thermal stabilization and self-administered delivery of heat-sensitive medical countermeasures using room-temperature dehydration technology, under a total small business set-aside.
This is a Phase II SBIR effort with firm fixed price terms and a completion date of April 12, 2028. Place of performance is Princeton, NJ. The work builds on Inaedis's Rapid Room-Temperature Aerosol Dehydration (RTAD) technology platform, which converts liquid biopharmaceutical formulations into shelf-stable bioactive powders suitable for pulmonary, nasal, and transdermal delivery routes. The technology addresses military objectives to improve vaccine stability and reduce pharmaceutical logistics complexity by eliminating cold chain infrastructure requirements.
Description
Thermal stabilization and self-administered delivery of heat-sensitive medical countermeasures using room temperature dehydration technology resulting in a phase II small business innovation research (SBIR) effort.
Quick answers
Who was awarded contract W911SR26CA013?
W911SR26CA013 was awarded to Inaedis, Inc. by ACC Aberdeen Proving Ground (Army Contracting Command) on April 9, 2026.
How much is contract W911SR26CA013 worth?
The government has obligated $1,396,936 on W911SR26CA013.
Which agency awarded contract W911SR26CA013?
ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911SR26CA013, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).
Was contract W911SR26CA013 competed?
The extent of competition for W911SR26CA013 was full and open competition after exclusion of sources. The government received 13 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award